Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share (NASDAQ:RAIN)

cagkansayin/iStock via Getty Images

Rain Oncology (NASDAQ:RAIN) has agreed to be acquired by Pathos AI for $1.16, per share in cash and a potential cash payments of up to approximately $0.17 per share.

Based in Newark, California the oncology company stated that the initial cash offer

acquiredcashNASDAQRAINOncologyPathosRainshare
Comments (0)
Add Comment